BlueSpruce Investments LP Invests $583,000 in Intuitive Surgical, Inc. $ISRG

BlueSpruce Investments LP acquired a new position in Intuitive Surgical, Inc. (NASDAQ:ISRG) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 1,073 shares of the medical equipment provider’s stock, valued at approximately $583,000. Intuitive Surgical makes up 0.0% of BlueSpruce Investments LP’s portfolio, making the stock its 27th biggest holding.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. Norges Bank purchased a new position in shares of Intuitive Surgical in the second quarter valued at $2,569,260,000. Vanguard Group Inc. grew its holdings in Intuitive Surgical by 2.1% during the 2nd quarter. Vanguard Group Inc. now owns 33,335,833 shares of the medical equipment provider’s stock valued at $18,115,025,000 after buying an additional 670,302 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its position in shares of Intuitive Surgical by 20.1% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 3,393,951 shares of the medical equipment provider’s stock valued at $1,680,922,000 after acquiring an additional 566,979 shares in the last quarter. Jennison Associates LLC boosted its stake in shares of Intuitive Surgical by 20.4% during the second quarter. Jennison Associates LLC now owns 3,122,390 shares of the medical equipment provider’s stock valued at $1,696,738,000 after acquiring an additional 528,359 shares during the last quarter. Finally, Wellington Management Group LLP raised its stake in Intuitive Surgical by 15.0% in the 1st quarter. Wellington Management Group LLP now owns 3,499,052 shares of the medical equipment provider’s stock valued at $1,732,975,000 after purchasing an additional 457,080 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts recently issued reports on ISRG shares. Leerink Partners raised their target price on shares of Intuitive Surgical from $593.00 to $600.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 22nd. UBS Group set a $600.00 price objective on shares of Intuitive Surgical and gave the company a “neutral” rating in a research note on Thursday, October 23rd. Rothschild & Co Redburn increased their price target on shares of Intuitive Surgical from $610.00 to $615.00 and gave the stock a “buy” rating in a research note on Thursday, October 23rd. Zacks Research upgraded Intuitive Surgical from a “hold” rating to a “strong-buy” rating in a report on Friday, October 24th. Finally, HSBC lifted their target price on Intuitive Surgical from $595.00 to $644.00 and gave the company a “buy” rating in a report on Thursday, October 23rd. Two research analysts have rated the stock with a Strong Buy rating, sixteen have given a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $608.79.

Intuitive Surgical Stock Down 0.9%

Shares of NASDAQ ISRG opened at $542.32 on Friday. The stock has a market capitalization of $194.41 billion, a P/E ratio of 71.74, a PEG ratio of 5.03 and a beta of 1.68. The stock’s 50 day moving average price is $529.62 and its two-hundred day moving average price is $506.00. Intuitive Surgical, Inc. has a 52-week low of $425.00 and a 52-week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.99 by $0.41. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The business had revenue of $2.51 billion for the quarter, compared to analyst estimates of $2.41 billion. During the same period in the prior year, the company posted $1.84 EPS. The business’s revenue was up 22.9% compared to the same quarter last year. On average, analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Insider Buying and Selling

In other news, EVP Henry L. Charlton sold 13,731 shares of the business’s stock in a transaction on Wednesday, November 12th. The shares were sold at an average price of $580.00, for a total transaction of $7,963,980.00. Following the completion of the transaction, the executive vice president owned 3,056 shares of the company’s stock, valued at approximately $1,772,480. The trade was a 81.80% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, CEO David J. Rosa sold 24,500 shares of Intuitive Surgical stock in a transaction dated Friday, October 24th. The shares were sold at an average price of $547.55, for a total transaction of $13,414,975.00. Following the completion of the sale, the chief executive officer owned 234,256 shares in the company, valued at approximately $128,266,872.80. This represents a 9.47% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 109,043 shares of company stock valued at $60,816,225 over the last 90 days. 0.70% of the stock is owned by corporate insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.